Drugs / Tetanus Vaccine, Adsorbed
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT06120751 Comparator | Mar → Apr 2024 | tetanus | CanSino Biologics Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tetanus Vaccine, Adsorbed | “Tetanus Vaccine, Adsorbed (TT)” NCT06120751 ↗ |
| Known as | TT | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06120751 ↗ |
| Modality | Vaccine | “Tetanus Vaccine, Adsorbed (TT)” NCT06120751 ↗ |